Xunming Ji Selected Research

Inflammation (Inflammations)

1/2024	Hypoxic Conditioning: A Potential Perioperative Strategy to Reduce Abdominal Aortic Occlusion-Related Injury in Mouse Proximal and Distal Organs.
1/2024	More severe initial manifestations and worse short-term functional outcome of intracerebral hemorrhage in the plateau than in the plain.
10/2023	The neuroprotective role of prolonged normobaric oxygenation applied during ischemia and in the early stage of reperfusion in cerebral ischemic rats.
1/2023	Intermittent hypoxic conditioning restores neurological dysfunction of mice induced by long-term hypoxia.
6/2022	Tert-butylhydroquinone prevents neuroinflammation and relieves depression via regulation of NLRP3 signaling in mice.
1/2022	Cognitive impairment caused by hypoxia: from clinical evidences to molecular mechanisms.
2/2021	Identifying Biomarkers Associated with Venous Infarction in Acute/Subacute Cerebral Venous Thrombosis.
1/2021	Loss of Wip1 aggravates brain injury after ischaemia/reperfusion by overactivating microglia.
1/2021	Neuroprotective effects and mechanisms of ischemic/hypoxic preconditioning on neurological diseases.
1/2021	A systemic review into carotid plaque features as predictors of restenosis after carotid endarterectomy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xunming Ji Research Topics

Disease

135	Stroke (Strokes) 04/2024 - 01/2006
125	Ischemic Stroke 05/2024 - 02/2009
63	Ischemia 05/2024 - 01/2007
59	Brain Ischemia (Cerebral Ischemia) 05/2024 - 01/2006
55	Infarction (Infarctions) 03/2024 - 08/2008
32	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2023 - 05/2009
29	Hypothermia 01/2024 - 01/2007
27	Brain Injuries (Brain Injury) 11/2023 - 01/2007
22	Hypoxia (Hypoxemia) 01/2024 - 09/2011
21	Reperfusion Injury 01/2023 - 06/2011
17	Cerebral Hemorrhage 04/2024 - 02/2009
16	Cerebral Infarction 04/2024 - 01/2006
16	Inflammation (Inflammations) 01/2024 - 02/2010
15	Pathologic Constriction (Stenosis) 11/2023 - 01/2009
13	Thrombosis (Thrombus) 01/2023 - 11/2007
12	Hemorrhage 04/2024 - 01/2009
10	Venous Thrombosis (Deep-Vein Thrombosis) 02/2024 - 01/2018
10	Intracranial Hemorrhages (Intracranial Hemorrhage) 09/2023 - 10/2018
9	Atherosclerosis 12/2022 - 05/2016
8	Hyperoxia 05/2024 - 01/2013
8	Edema (Dropsy) 05/2024 - 02/2012
8	Hypertension (High Blood Pressure) 05/2024 - 01/2009
8	Neoplasms (Cancer) 01/2022 - 01/2009
7	Headache (Headaches) 02/2024 - 01/2018
7	Hemorrhagic Stroke 12/2023 - 03/2012
7	Brain Edema (Cerebral Edema) 07/2023 - 02/2012
6	Cognitive Dysfunction 11/2023 - 01/2019
6	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2023 - 03/2009
5	Intracranial Sinus Thrombosis (Sinus Thrombosis) 04/2023 - 05/2013
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 02/2010
5	Transient Ischemic Attack 01/2023 - 05/2009
5	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 01/2022 - 01/2009
5	Necrosis 01/2021 - 01/2013
4	Nervous System Diseases (Neurological Disorders) 02/2024 - 01/2014
4	Vascular Diseases (Vascular Disease) 12/2023 - 08/2018
4	Hyperhomocysteinemia 02/2022 - 05/2016
4	Glioma (Gliomas) 01/2021 - 02/2010
3	Atrial Fibrillation 02/2024 - 10/2017
3	Acidosis 01/2024 - 05/2009
3	Atrophy 01/2023 - 01/2019
3	Embolic Stroke 01/2023 - 02/2017
3	Atherosclerotic Plaque (Atheroma) 01/2022 - 07/2017

Drug/Important Bio-Agent (IBA)

40	Oxygen (Dioxygen)IBA 05/2024 - 05/2011
40	Neuroprotective AgentsIBA 05/2024 - 01/2007
37	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2007
27	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2006
16	salicylhydroxamic acid (SHAM)IBA 12/2022 - 06/2011
16	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 02/2009
14	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 05/2009
11	MicroRNAs (MicroRNA)IBA 01/2022 - 06/2013
9	Therapeutic UsesIBA 01/2024 - 02/2010
9	Ethanol (Ethyl Alcohol)IBA 01/2017 - 01/2012
8	OccludinIBA 01/2024 - 11/2015
8	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2019 - 08/2014
7	Small Interfering RNA (siRNA)IBA 05/2024 - 06/2011
7	CytokinesIBA 12/2021 - 03/2014
7	Erythropoietin FDA Link 01/2016 - 05/2009
6	Tirofiban (Aggrastat)FDA Link 04/2024 - 12/2017
6	Retinaldehyde (Retinal)IBA 11/2023 - 05/2014
6	ZincIBA 10/2023 - 04/2014
6	AntioxidantsIBA 01/2021 - 10/2010
6	Evans Blue (Blue, Evans)FDA Link 01/2020 - 06/2011
6	Messenger RNA (mRNA)IBA 06/2018 - 08/2008
6	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2018 - 01/2006
5	Hematoxylin (Haematoxylon)IBA 01/2024 - 08/2008
5	Eosine Yellowish-(YS) (Eosin)IBA 01/2024 - 08/2008
5	Matrix Metalloproteinases (MMPs)IBA 10/2023 - 01/2009
5	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2022 - 03/2009
5	oxidized low density lipoproteinIBA 12/2021 - 09/2016
4	AnticoagulantsIBA 10/2023 - 04/2022
4	CholesterolIBA 02/2022 - 09/2016
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2022 - 04/2019
4	LipidsIBA 01/2022 - 07/2017
4	C-Reactive ProteinIBA 02/2021 - 06/2011
4	fibrin fragment D (D-dimer)IBA 01/2020 - 05/2009
4	Fibrinogen (Factor I)FDA Link 08/2019 - 06/2011
4	IceIBA 08/2018 - 06/2016
4	TOR Serine-Threonine KinasesIBA 01/2018 - 12/2013
4	Chlorpromazine (Thorazine)FDA Link 12/2017 - 05/2015
4	Promethazine (Promet)FDA LinkGeneric 12/2017 - 05/2015
4	Collagenases (Collagenase)FDA Link 01/2016 - 05/2011
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2024 - 03/2016
3	Warfarin (Coumadin)FDA LinkGeneric 02/2024 - 05/2013
3	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 12/2023 - 01/2018
3	Tight Junction ProteinsIBA 10/2023 - 01/2016
3	Indicators and Reagents (Reagents)IBA 01/2023 - 05/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 10/2016
3	Branched-Chain Amino AcidsIBA 01/2023 - 12/2002
3	Peptides (Polypeptides)IBA 11/2022 - 01/2018
3	BatroxobinIBA 10/2022 - 01/2006
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 02/2015
3	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 05/2009

Therapy/Procedure

92	Therapeutics 05/2024 - 12/2002
35	Thrombectomy 02/2024 - 05/2013
20	Induced Hypothermia 01/2024 - 05/2009
16	Ischemic Postconditioning 01/2023 - 06/2011
11	Stents 02/2024 - 01/2009
6	Catheters 08/2023 - 01/2009
6	Intra-Arterial Infusions 01/2016 - 06/2011
3	General Anesthesia 01/2024 - 08/2019